NGS identified mutations in the TP53, Neurofibromin 1 (NF1), Cyclin‐Dependent Kinase Inhibitor 2A (CDKN2A), Multiple Endocrine Neoplasia type 1 (MEN1), Catenin Beta 1 (CTNNB1), and Ataxia‐Telangiectasia Mutated (ATM) genes to be the most common [80, 81, 82]. This evidence concerns the gene NF1 and Neoplasm of the endocrine system.